5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 6.56▼ | 6.57▼ | 6.56▼ | 6.60▼ | 6.36▲ |
MA10 | 6.57▼ | 6.57▼ | 6.55▼ | 6.56▲ | 6.68▼ |
MA20 | 6.55▼ | 6.56▼ | 6.58▼ | 6.32▲ | 6.82▼ |
MA50 | 6.57▼ | 6.60▼ | 6.59▼ | 6.72▼ | 6.05▲ |
MA100 | 6.61▼ | 6.55▼ | 6.42▲ | 6.74▼ | 5.73▲ |
MA200 | 6.55▼ | 6.30▲ | 6.46▲ | 6.16▲ | 5.42▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▲ | 0.004▲ | 0.000▼ | 0.055▲ | -0.115▼ |
RSI | 46.983▼ | 46.275▼ | 46.679▼ | 51.271▲ | 50.684▲ |
STOCH | 34.722 | 56.995 | 56.516 | 70.893 | 29.031 |
WILL %R | -91.667▼ | -68.750 | -57.895 | -16.842▲ | -71.508 |
CCI | -71.175 | -34.253 | -22.029 | 49.588 | -53.035 |
RSI | $KMDA RSI(14) Crossed Above 50 | Set Alert |
Tuesday, April 22, 2025 06:56 AM
From protecting against infections for people who had a solid organ or bone marrow transplant to treating hepatitis B infection, or preventing deadly Rabies disease in individuals who were exposed to ...
|
Wednesday, April 16, 2025 08:37 AM
Kamada is a global biopharmaceutical company with a portfolio of assets indicated for rare and serious conditions. The company reports it is a leader in the specialty plasma-derived field, focused on ...
|
Wednesday, April 16, 2025 01:31 AM
Kamada is a global biopharmaceutical company with a portfolio of assets indicated for rare and serious conditions. The company reports it is a leader in the specialty plasma-derived field, focused on ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 6.52 | 6.61 | 6.50 | 6.57 | 30,624 |
30/04/25 | 6.52 | 6.57 | 6.35 | 6.47 | 42,480 |
29/04/25 | 6.57 | 6.68 | 6.54 | 6.61 | 32,284 |
28/04/25 | 6.64 | 6.70 | 6.53 | 6.64 | 52,011 |
25/04/25 | 6.64 | 6.71 | 6.5752 | 6.69 | 27,718 |
24/04/25 | 6.60 | 6.73 | 6.59 | 6.62 | 41,667 |
23/04/25 | 6.56 | 6.6252 | 6.52 | 6.58 | 62,828 |
22/04/25 | 6.44 | 6.4771 | 6.37 | 6.47 | 87,646 |
21/04/25 | 6.41 | 6.50 | 6.36 | 6.40 | 59,663 |
17/04/25 | 6.48 | 6.57 | 6.40 | 6.50 | 97,478 |
|
|
||||
|
|
||||
|
|